2nd Quarter - Report

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 3019 - No Big Blockbuster Bailouts Act (NOBBBA) Cameron's Law (HR 1414) EPIC Act (HR 1492, S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies

LobbyistCovered position, as disclosed
SUSANNA AGUIRRE HASTINGS —
CATE MCCANLESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1414 (119th), H.R. 1492 (119th), S. 3019 (119th), H.R. 1672 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.